Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01637077 · ClinicalTrials.gov registry record · Phase 2

Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel

A Phase 2 study of Pain and Peripheral Neuropathy, sponsored by Academic and Community Cancer Research United.

Completed
Registry status
Phase 2
Development phase
46
Enrollment target
6
Study locations

NCT01637077 is a Phase 2 study of Pain and Peripheral Neuropathy that has completed, run by Academic and Community Cancer Research United. The registered enrollment target is 46 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (85% lower). The trial reports 6 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01637077, a Phase 2 study of Pain and Peripheral Neuropathy, has completed, sponsored by Academic and Community Cancer Research United.

COMPLETED
Registry status
Phase 2
Development phase
46 participants
Enrollment target
6
Study locations

Study Summary

This randomized pilot clinical trial studies pregabalin in preventing acute pain syndrome in patients receiving paclitaxel. Pregabalin may control the pain caused by cancer treatment.

Conditions Studied

Pain Peripheral Neuropathy

Interventions

  • DRUG placebo
  • OTHER questionnaire administration
  • DRUG pregabalin

Study Locations (6)

Minnesota

  • Essentia Health-Duluth CCOP - Duluth
  • Mayo Clinic - Rochester
  • Coborn Cancer Center at Saint Cloud Hospital - Saint Cloud

Kansas

  • Cancer Center of Kansas - Wichita

Nebraska

  • Missouri Valley Cancer Consortium - Omaha

Wisconsin

  • Marshfield Clinic - Marshfield Center - Marshfield

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2012-01
Est. Completion 2016-04
Phase Phase 2

Sponsor

Academic and Community Cancer Research United

42 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01637077

The ClinicalTrials.gov registry entry for NCT01637077 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (85% lower). The listed sponsor is Academic and Community Cancer Research United, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 3 interventions - of which placebo is the first listed.

NCT01637077 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Minnesota, Kansas, Nebraska.

Frequently Asked Questions

What is clinical trial NCT01637077 about?

NCT01637077 is a clinical study titled "Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel". This randomized pilot clinical trial studies pregabalin in preventing acute pain syndrome in patients receiving paclitaxel. Pregabalin may control the pain caused by cancer treatment.

What is the current status of trial NCT01637077?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 46 participants. The study started on 2012-01. Estimated completion is 2016-04.

What conditions does trial NCT01637077 study?

This clinical trial studies the following conditions: Pain, Peripheral Neuropathy.

What interventions are being tested in trial NCT01637077?

The interventions under investigation include: placebo (DRUG), questionnaire administration (OTHER), pregabalin (DRUG).

Who is sponsoring clinical trial NCT01637077?

This trial is sponsored by Academic and Community Cancer Research United, which has 42 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01637077 being conducted?

This trial has 6 study locations across Kansas, Minnesota, Nebraska, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pain

All registered trials for this condition

Peripheral Neuropathy

All registered trials for this condition

Kansas

All trials with a study site in Kansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.